Patent · US Active

Highly pure pentamycin

US8519162B2 · kind B2 · utility

0Cited by

0References

9Claims

0Family size

Assignee

Biolotus Biotechnology AG · CH

Inventors

Karl Reuter · Gundelfingen, DE
Viktor Meier · Gundelfingen, DE
Florian Stolz · Glückstadt, DE
Dieter Krimmer · Zug, CH
Cees Winninps · Fluh, CH

Key dates

Filing date	Mar 20, 2009
Grant date	Aug 27, 2013
Priority date	—
Expiry date	Apr 11, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07H17/08
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Described is pentamycin in a purity exceeding 95%, certain polymorphs and solvates of pentamycin, processes for their manufacture, and a method for decreasing the rate of degradation of pentamycin.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.